(±)-CP 55,940 is primarily utilized in research settings as a potent synthetic cannabinoid receptor agonist. It is extensively used in pharmacological studies to investigate the endocannabinoid system, particularly in understanding the binding and activation mechanisms of cannabinoid receptors CB1 and CB2. This compound aids in exploring the therapeutic potential of cannabinoids in various conditions such as pain management, inflammation, and neurodegenerative disorders. Additionally, it serves as a valuable tool in behavioral studies to assess the effects of cannabinoid receptor activation on mood, cognition, and motor function. Its high affinity for cannabinoid receptors makes it a key compound in developing and testing new cannabinoid-based therapies.